The board of directors of Kintor Pharmaceutical Limited hereby announced that Mr. Chengwei Liu has been appointed as a non-executive Director and a member of the audit committee of the Company with effect from 5 May 2022. Mr. Liu, aged 52, has been, and is currently the Chairman and President of Suzhou Oriza Holdings Corporation since March 2016. From December 1998 to March 2016, Mr. Liu served as a staff member, deputy director, director and deputy executive of Suzhou Industrial Park Administrative Committee.

From July 1995 to December 1998, Mr. Liu served as the deputy manager of the delivery department of Suzhou Commodity Exchange and a lawyer of Suzhou Future Law Firm. Save for his position as a non-executive Director of the Company, Mr. Liu is currently a director of S.F. HOLDING CO., LTD (a company listed on the Main Board of the Shenzhen Stock Exchange in China) and Zhongji Innolight Co. Ltd. (a company listed on the ChiNext Market of the Shenzhen Stock Exchange in China), respectively.

The Board further announced that Dr. Yan Wang has resigned as a non-executive Director and a member of the Audit Committee with effect from 5 May 2022 due to pursuit of his personal commitments.